beijing novartis pharma ltd

In 1996, two century old Swiss companies on the Rhine River, Ciba Cargill and Sanders, announced their merger to form Novartis. The group is headquartered in Basel, Switzerland. As of 2011, Novartis group has business in more than 140 countries and regions around the world, with 124000 full-time employees, net sales of US $58.6 billion, ranking second in the pharmaceutical industry in the world (according to the ranking of top 50 pharmaceutical companies in the world published by pharmaceutical managers in 2011), and core R & D expenditure of about US $9.6 billion. Novartis focuses on the field of medicine and health care, and has six diversified business combinations: innovative drugs, eye care (Alcon), cost saving non patented drugs (Sanders), preventive vaccines and diagnostic equipment, over-the-counter drugs and animal health products.

As a branch of Novartis group, Novartis animal health research, development, production and sales of animal health products, is the world's leading supplier of animal health products, with five R & D bases and six production bases in the world. Our goal: to save, extend and improve the lives of animals. The company's innovations in animal disease prevention, anti parasite, anti infection, farm hygiene and vaccines meet the needs of veterinary pet owners and livestock producers all over the world. In 2011, Novartis had net sales of $1.3 billion.

Novartis animal health (China) is a wholly-owned enterprise of Novartis in China, which was established in 1990 with a registered capital of US $30 million. The company's production base is located in Shanghai Fengxian 54 farm, with a full set of advanced production equipment and facilities. Since the establishment of the factory, the company has continuously improved its quality system, strictly abided by the Chinese veterinary drug production quality management standards and the quality policies of the Swiss headquarters, and became the first professional veterinary drug enterprise to pass the GMP certification of the Ministry of agriculture of China. At present, the company's main products are zhiyuanjing, kangshumi, fubenkang, Shanzi, yingdejing, yingdejing, aigit, etc. The products are not only sold well in China's domestic veterinary drug market, but also exported to Southeast Asia, South America, Australia and other countries and regions. With the need of business expansion, the company will soon bring a series of high-quality pet products into the Chinese market, please pay attention.

Novartis animal health (China) is committed to become the most outstanding animal health company in the eyes of Chinese customers and employees, and promote the healthy development of China's animal husbandry by continuously providing innovative products and leading services to customers.